Getting Generic Drugs to the Market

On Tuesday, four U.S. Senators introduced a bill aimed at preventing big pharmaceutical companies from using the Food and Drug Administration’s program called REMS (risk evaluation and mitigation strategy) program to prevent generic drugs from coming to market. Read article here…….

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.